Hematologic and cytogenetic responses in dasatinib trials.
Stage of disease . | No of patients . | CHR, % . | MCyR, % . | CCyR, % . |
---|---|---|---|---|
Abbreviations: CHR, complete hematologic response; CCyR, complete cytogenetic response; MCyR, major cytogenetic response. | ||||
Chronic phase16 | 186 | 90 | 52 | 39 |
Accelerated phase17 | 107 | 39 | 33 | 24 |
Myeloid blast crisis18 | 74 | 26 | 31 | 27 |
Lymphoid blast crisis18 | 42 | 26 | 50 | 43 |
Stage of disease . | No of patients . | CHR, % . | MCyR, % . | CCyR, % . |
---|---|---|---|---|
Abbreviations: CHR, complete hematologic response; CCyR, complete cytogenetic response; MCyR, major cytogenetic response. | ||||
Chronic phase16 | 186 | 90 | 52 | 39 |
Accelerated phase17 | 107 | 39 | 33 | 24 |
Myeloid blast crisis18 | 74 | 26 | 31 | 27 |
Lymphoid blast crisis18 | 42 | 26 | 50 | 43 |